Jay Galeota

Jay Galeota is President and Chief Executive Officer of Kallyope. Prior to joining Kallyope, he was President and Chief Executive Officer of Inheris BioPharma until May, 2020. Jay previously served as President of G&W Laboratories and Chief Strategy & Business Development Officer and President, Emerging Business at Merck & Co. He is a 33-year industry veteran and spent 28 years at Merck, where he held diverse positions across commercial operations, business development, strategy, and innovation, both globally and in the United States. Jay is known for his passion for innovation and development of breakthrough products and business opportunities. He holds a Bachelor of Science in biology from Villanova University and is a graduate of Harvard Business School’s Advanced Management Program. He served as an Independent Director at Melinta Therapeutics (MLNT) and Assertio Therapeutics (ASRT), and is on the boards of Hackensack Meridian Health System, Harvard Business School’s Healthcare Alumni Association, the New Jersey Symphony Orchestra, and the Metuchen Edison Woodbridge YMCA. Jay is also a member of Villanova University’s Dean's Advisory Council. In addition, Jay currently serves as Honorary Commander of the United States Air Force 113th Wing, DCANG, Joint Base Andrews and is a guest lecturer at the Wharton School of the University of Pennsylvania. Jay is also the co-author of publications in Harvard Business Review and Chief Executive.